for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Granules India Ltd

GRAN.NS

Latest Trade

114.10INR

Change

12.60(+12.41%)

Volume

7,496,455

Today's Range

102.55

 - 

119.85

52 Week Range

79.15

 - 

120.40

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
101.50
Open
102.90
Volume
7,496,455
3M AVG Volume
11.91
Today's High
119.85
Today's Low
102.55
52 Week High
120.40
52 Week Low
79.15
Shares Out (MIL)
254.25
Market Cap (MIL)
25,806.13
Forward P/E
8.79
Dividend (Yield %)
0.99

Next Event

Q2 2020 Granules India Ltd Earnings Call

Latest Developments

More

Granules India Receives FDA EIR For Hyderabad Plant With One Observation

Ajinomoto Bio-Pharma Services Acquires Remaining Interest In Granules Omnichem Joint Venture In India

Granules India June Qtr Consol Profit Rises

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Granules India Ltd

Granules India Limited is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). The Company's business operations include three areas: core business, emerging business, and contract research and manufacturing services (CRAMS). Its products in Core business include Paracetamol, Ibuprofen, Guaifenesin and Metformin. The Company operates a healthcare division, Granules Consumer Healthcare (GCH). The Company, through an acquisition, has access to over 10 APIs, as well as intermediates in therapeutic categories, such as anti-histaminic, antihypertensive and anti-convulsants. The Company's PFI products include Compresso PAP 97 S, Compresso PAP 90 CPC and Paracetamol Caffeine Combo 77.4. The Company's FDs include Paracetamol/Acetaminophen, and Acetaminophen and Methocarbamol.

Industry

Biotechnology & Drugs

Contact Info

Second Floor

Block III, My Home Hub, Madhapur

+91.40.66760000

http://www.granulesindia.com/

Executive Leadership

K. Ganesh

Chief Financial Officer

Chaitanya Tummala

Compliance Officer, Company Secretary

Chigurupati Krishna Prasad

Chairman of the Board, Managing Director

Harsha Chigurupati

Executive Director

Uma Devi Chigurupati

Non-Independent Executive Director

Key Stats

1.67 mean rating - 9 analysts
Sell
Hold
Buy
Revenue (MM, INR)

2017

14.1K

2018

16.8K

2019

22.8K

2020(E)

26.1K
EPS (INR)

2017

7.480

2018

5.470

2019

9.280

2020(E)

11.552
Price To Earnings (TTM)
9.67
Price To Sales (TTM)
1.07
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
6.84
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up